Published in J Exp Med on June 01, 1998
Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest (2000) 2.25
Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J Exp Med (2006) 2.11
Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J Exp Med (2000) 1.51
Antigen-capturing cells can masquerade as memory B cells. J Exp Med (2003) 1.32
Structural and functional anatomy of the globular domain of complement protein C1q. Immunol Lett (2004) 1.11
Role of the classical pathway of complement activation in experimentally induced polymicrobial peritonitis. Infect Immun (2001) 1.05
The role of complement in the acquired immune response. Immunology (2000) 0.98
Complement and its role in protection and pathogenesis of flavivirus infections. Vaccine (2008) 0.96
Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation. J Leukoc Biol (2014) 0.94
Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites. Infect Immun (2001) 0.94
The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy. Am J Transplant (2008) 0.92
Requirement for complement in antibody responses is not explained by the classic pathway activator IgM. Proc Natl Acad Sci U S A (2011) 0.90
The B cell receptor itself can activate complement to provide the complement receptor 1/2 ligand required to enhance B cell immune responses in vivo. J Exp Med (2003) 0.88
Complement receptors 1 and 2 in murine antibody responses to IgM-complexed and uncomplexed sheep erythrocytes. PLoS One (2012) 0.87
Food restriction compromises immune memory in deer mice (Peromyscus maniculatus) by reducing spleen-derived antibody-producing B cell numbers. Physiol Biochem Zool (2008) 0.80
Role of B cells in maintaining helper T-cell memory. Philos Trans R Soc Lond B Biol Sci (2000) 0.80
Complement modulation of T cell immune responses during homeostasis and disease. J Leukoc Biol (2014) 0.79
IgG Suppresses Antibody Responses in Mice Lacking C1q, C3, Complement Receptors 1 and 2, or IgG Fc-Receptors. PLoS One (2015) 0.78
Complement-activating IgM enhances the humoral but not the T cell immune response in mice. PLoS One (2013) 0.78
IgG3-antigen complexes are deposited on follicular dendritic cells in the presence of C1q and C3. Sci Rep (2017) 0.75
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86
Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science (1987) 13.03
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet (1998) 8.20
Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol (1990) 7.93
Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol (1988) 6.51
Mechanism of antigen-driven selection in germinal centres. Nature (1990) 5.26
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science (1996) 4.35
Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J Immunol (1989) 4.20
The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity (1996) 4.02
The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory. Immunol Rev (1980) 3.53
Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol (1996) 3.24
Antigen-driven selection of virgin and memory B cells. Immunol Rev (1986) 3.10
The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells. Immunol Rev (1980) 2.95
Role of complement in induction of the allergic response. Nat New Biol (1972) 2.90
Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci U S A (1996) 2.71
B-cell memory is short-lived in the absence of antigen. Nature (1988) 2.57
Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol (1996) 2.51
Complement dependence of localisation of aggregated IgG in germinal centres. Scand J Immunol (1975) 2.48
Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med (1992) 2.47
Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med (1974) 2.45
Determination of total and merecaptothanol-resistant antibody in the same serum sample. Clin Exp Immunol (1970) 2.36
Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity (1996) 2.29
CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature (1995) 2.23
Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity (1996) 2.22
Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J Exp Med (1996) 2.18
B cells solicit their own help from T cells. J Exp Med (1996) 2.16
Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J Exp Med (1997) 2.14
Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J Exp Med (1992) 2.05
The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity (1997) 2.00
Production of interferon-gamma during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology (1989) 1.99
The localization of immunoglobulin and immune complexes in lymphoid tissue. Immunology (1970) 1.95
Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J Immunol (1985) 1.91
Dendritic cells capable of stimulating T cells in germinal centres. Nature (1996) 1.90
Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells. Immunol Rev (1997) 1.78
In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J Exp Med (1990) 1.67
A novel in vivo follicular dendritic cell-dependent iccosome-mediated mechanism for delivery of antigen to antigen-processing cells. J Immunol (1988) 1.66
Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science (1991) 1.63
The generation of memory cells. I. The role of C3 in the generation of B memory cells. Immunology (1977) 1.59
The localization of aggregated human -globulin in the spleens of normal mice. Immunology (1973) 1.57
Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med (1996) 1.52
Sequential antigen-specific growth of T cells in the T zones and follicles in response to pigeon cytochrome c. Eur J Immunol (1996) 1.49
Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4. J Immunol (1997) 1.41
Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N Engl J Med (1979) 1.41
Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J Immunol (1994) 1.30
The role of complement in the induction of antibody responses. Clin Exp Immunol (1983) 1.16
Phagocytic cell molecules that bind the collagen-like region of C1q. Involvement in the C1q-mediated enhancement of phagocytosis. J Biol Chem (1991) 1.16
Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40. J Immunol (1997) 1.12
Marginal zone B cells express CR1 and CR2 receptors. Eur J Immunol (1984) 1.10
Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. Int Immunol (1990) 1.10
Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J Immunol (1995) 1.09
Selective inhibition of immune complex trapping by follicular dendritic cells with monoclonal antibodies against rat C3. Eur J Immunol (1992) 1.09
Impaired humoral immune response in complement C3-deficient guinea pigs: absence of secondary antibody response. Eur J Immunol (1986) 1.09
Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J Immunol (1988) 1.07
Amplified follicular immune complex deposition in mice lacking the Fc receptor gamma-chain does not alter maturation of the B cell response. J Immunol (1997) 1.07
Isolation of follicular dendritic cells from human tonsils and adenoids. III. Analysis of their Fc receptors. Immunology (1985) 1.05
Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M(r) component of the C1q receptor. Immunity (1995) 1.05
Follicular dendritic cell-derived antigen and accessory activity in initiation of memory IgG responses in vitro. J Immunol (1996) 1.02
Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors. Eur J Immunol (1991) 1.01
Enhanced Ig production by human peripheral lymphocytes induced by aggregated C1q. J Immunol (1990) 0.97
Immunoglobulin isotype regulation by antigen-presenting cells in vivo. Eur J Immunol (1994) 0.97
Normal B cells fail to secrete interleukin-12. Eur J Immunol (1997) 0.91
Functional aspects of the C1q receptors. Behring Inst Mitt (1993) 0.85
A hemolytic plaque assay for the detection of direct and indirect antibody-forming cells to keyhole limpet hemocyanin. J Immunol Methods (1975) 0.83
Structural differences between the two human complement C4 isotypes affect the humoral immune response. J Exp Med (1992) 0.82
Complement component C1 and the collectins: parallels between routes of acquired and innate immunity. Immunol Today (1998) 0.82
Studies on immunosuppression by cobra venom factor. III. On early responses to sheep erythrocytes in C5-deficient mice. J Immunol (1978) 0.78
C3 deficiencies. Curr Top Microbiol Immunol (1990) 0.76
Immunological memory and protective immunity: understanding their relation. Science (1996) 10.02
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet (1998) 8.20
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest (1989) 7.60
Mice lacking MHC class II molecules. Cell (1991) 6.25
The effect of education, assessment and a standardised prescription on postoperative pain management. The value of clinical audit in the establishment of acute pain services. Anaesthesia (1998) 4.72
Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J (1994) 4.40
Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med (1999) 3.88
Role of PML in cell growth and the retinoic acid pathway. Science (1998) 3.82
PML is essential for multiple apoptotic pathways. Nat Genet (1998) 3.75
A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med (2000) 3.65
Antigen-driven selection of virgin and memory B cells. Immunol Rev (1986) 3.10
HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature (1987) 2.96
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) (1983) 2.86
Nonequivalent nuclear location of immunoglobulin alleles in B lymphocytes. Nat Immunol (2001) 2.83
Complement deficiency and disease. Immunol Today (1991) 2.77
Do women with acute myocardial infarction receive the same treatment as men? BMJ (1994) 2.70
Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science (1992) 2.60
Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol (2000) 2.59
Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol (1992) 2.54
Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci U S A (1997) 2.47
Chemical and physiological characterization of fluo-4 Ca(2+)-indicator dyes. Cell Calcium (2000) 2.32
Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart (1999) 2.31
Complement facilitates early prion pathogenesis. Nat Med (2001) 2.30
CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature (1995) 2.23
Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet (1990) 2.22
Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1). Eur J Immunol (1984) 2.20
B cells solicit their own help from T cells. J Exp Med (1996) 2.16
Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine. J Chromatogr B Biomed Sci Appl (2000) 2.16
Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register. BMJ (1997) 2.08
Indigenous Australians and liquor licensing restrictions. Addiction (2000) 2.03
Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med (1990) 2.03
Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat Med (2001) 1.99
Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation (1990) 1.91
Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis (1999) 1.88
Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci U S A (2006) 1.87
Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci U S A (2007) 1.86
Melanomas in renal transplant recipients. Br J Dermatol (2006) 1.85
Statin prescribing in Nottingham general practices: a cross-sectional study. J Public Health Med (1999) 1.77
Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma. J Clin Invest (1982) 1.77
Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol (1985) 1.76
Resuscitation from out-of-hospital cardiac arrest: is survival dependent on who is available at the scene? Heart (1999) 1.76
Use of statins in general practices, 1996-8: cross sectional study. BMJ (2000) 1.73
Migrant mu+ delta+ and static mu+ delta- B lymphocyte subsets. Eur J Immunol (1982) 1.71
Follicular dendritic cell-dependent adhesion and proliferation of B cells in vitro. J Immunol (1992) 1.69
Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. Blood (1997) 1.69
Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood (2001) 1.65
Public health improvement in Iran--lessons from the last 20 years. Public Health (2004) 1.64
C1q and systemic lupus erythematosus. Immunobiology (1998) 1.63
Inactivation of oriented bacteria with polarized ultraviolet light. Biophys J (1965) 1.61
The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms. J Immunol (1988) 1.57
Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4. Br J Pharmacol (1983) 1.56
Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nat Med (1997) 1.56
Using telecommunication technology to manage children with diabetes: the Computer-Linked Outpatient Clinic (CLOC) Study. Diabetes Educ (1995) 1.56
Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide. Br Med J (Clin Res Ed) (1982) 1.50
Changes in the process of care for Medicaid patients with schizophrenia in Utah's Prepaid Mental Health Plan. Psychiatr Serv (1998) 1.49
Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis (1989) 1.48
ACE inhibitors for myocardial infarction and unstable angina. Lancet (1993) 1.47
Hereditary C1q deficiency and systemic lupus erythematosus. QJM (1994) 1.47
Lupus, DNase and defective disposal of cellular debris. Nat Genet (2000) 1.47
Identifying the risk of death following hospital discharge in patients admitted with a suspected acute myocardial infarction in whom the diagnosis is not confirmed. Eur Heart J (2000) 1.46
Ultraviolet-radiation-induced keratinocyte apoptosis in C1q-deficient mice. J Invest Dermatol (2001) 1.44
Clinical and immunologic features of livedo reticularis in lupus: a case-control study. Am J Med (1989) 1.44
Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab (1990) 1.40
Buerger's disease and protein S deficiency: successful treatment with prostacyclin. Clin Exp Rheumatol (1995) 1.40
A human monoclonal antiphospholipid antibody that is representative of serum antibodies and is germline encoded. Arthritis Rheum (1995) 1.40
Cellular interactions involved in Th cell memory. J Immunol (2000) 1.38
Anti-PL 4 in patients with systemic lupus erythematosus with severe renal and haematological disease. QJM (1997) 1.38
Malabsorption caused by coeliac disease in patients who have scleroderma. Br J Rheumatol (1995) 1.38
Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. J Immunol (2001) 1.36
Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: a feedback regulation of Th1 development. J Immunol (1999) 1.36
Absorption and attenuation of visible and near-infrared light in water: dependence on temperature and salinity. Appl Opt (1997) 1.35
Formaldehyde in the home--some environmental disease perspectives. Minn Med (1980) 1.33
MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Arthritis Rheum (2005) 1.32
Differences in the recruitment of virgin B cells into antibody responses to thymus-dependent and thymus-independent type-2 antigens. Eur J Immunol (1986) 1.31
Relation of intra-splenic migration of marginal zone B cells to antigen localization on follicular dendritic cells. Immunology (1984) 1.28
A survey of acute pain services in the United Kingdom. BMJ (1995) 1.27
Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations. Blood (1993) 1.26
Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J Immunol (1998) 1.25
Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells. Mol Cell Biol (1991) 1.25
Percutaneous initiation of cardiopulmonary bypass. Ann Thorac Surg (1983) 1.25
The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans. Clin Exp Immunol (1989) 1.24
Influence of ambulance crew's length of experience on the outcome of out-of-hospital cardiac arrest. Eur Heart J (1999) 1.24
Effects of group response-cost procedures on cash shortages in a small business. J Appl Behav Anal (1976) 1.24